Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)
- Authors:
- USP affiliated authors: KUPA, LEONARD DE VINCI KANDA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM ; SHINJO, SAMUEL KATSUYUKI - FM ; SARTORI, ANA MARLI CHRISTOVAM - FM ; ANTONANGELO, LEILA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1136/annrheumdis-2021-222096
- Subjects: VACINAÇÃO; DOENÇAS AUTOIMUNES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of the rheumatic diseases
- ISSN: 0003-4967
- Volume/Número/Paginação/Ano: v. 81, n. 7, p. 1036-1043, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
AIKAWA, Nadia Emi et al. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, v. 81, n. 7, p. 1036-1043, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-222096. Acesso em: 05 nov. 2024. -
APA
Aikawa, N. E., Kupa, L. de V. K., Medeiros-Ribeiro, A. C., Saad, C. G. S., Pereira, R. M. R., Shinjo, S. K., et al. (2022). Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, 81( 7), 1036-1043. doi:10.1136/annrheumdis-2021-222096 -
NLM
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096 -
Vancouver
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096 - Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring
- SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy
- Reduced ovarian reserve in patients with adult polymyositis
- Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
- Subclinical Reduced Ovarian Reserve in Adult Polymiositis Patients
- Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome
- Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE
- Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study
Informações sobre o DOI: 10.1136/annrheumdis-2021-222096 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
